Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?

J Infect. 2020 Nov;81(5):816-846. doi: 10.1016/j.jinf.2020.06.073. Epub 2020 Jun 30.

Abstract

For the first 3 months of COVID-19 pandemic, COVID-19 was expected to be an immunizing non-relapsing disease. We report a national case series of 11 virologically-confirmed COVID-19 patients having experienced a second clinically- and virologically-confirmed acute COVID-19 episode. According to the clinical history, we discuss either re-infection or reactivation hypothesis. Larger studies including further virological, immunological and epidemiologic data are needed to understand the mechanisms of these recurrences.

Publication types

  • Letter
  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Betacoronavirus / genetics*
  • COVID-19
  • Coronavirus Infections / physiopathology*
  • Coronavirus Infections / virology
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / physiopathology*
  • Pneumonia, Viral / virology
  • RNA, Viral / blood
  • RNA, Viral / genetics
  • Recurrence
  • Retrospective Studies
  • Reverse Transcriptase Polymerase Chain Reaction
  • SARS-CoV-2
  • Young Adult

Substances

  • RNA, Viral